PMID- 35988282 OWN - NLM STAT- MEDLINE DCOM- 20220823 LR - 20220901 IS - 1165-158X (Electronic) IS - 0145-5680 (Linking) VI - 68 IP - 4 DP - 2022 Apr 30 TI - Effect of Rosuvastatin on Myocardial Apoptosis in HypertensiveRats Through SIRT1/NF-kappaB Signaling Pathway. PG - 194-201 LID - 10.14715/cmb/2022.68.4.23 [doi] AB - The study aimed to observe the effect of rosuvastatin on myocardial apoptosis in hypertensive rats through the silent information regulator 1 (SIRT1)/nuclear factor-kappaB (NF-kappaB) signaling pathway. The spontaneously hypertensive rat (SHR) model was established, and the rats were randomly divided into the SHR group, Rosuvastatin group and Control group. The blood pressure, creatine kinase (CK) and other myocardial indexes in each group were detected, the cardiac function indexes of rats were determined using magnetic resonance imaging (MRI) and echocardiography (ECG), and tumor necrosis factor-alpha (TNF-alpha) and interleukin-6 (IL-6) in myocardial tissues were detected via enzyme-linked immunosorbent assay (ELISA). Moreover, the apoptosis level of myocardial tissues was detected using terminal deoxynucleotidyl transferase-mediated dUTP nick end labeling (TUNEL) staining. Finally, the expression levels of the SIRT1/NF-kappaB signaling pathway and apoptosis genes and proteins in myocardial tissues in each group were detected via quantitative polymerase chain reaction (qPCR) and Western blotting. In the SHR group, the blood pressure, the levels of serum creatinine (CR) and CK were increased (p<0.05). In the SHR group, both fractional shortening (FS%) and ejection fraction (EF%) were obviously lower than those in the control group (p<0.05), while both left ventricular end-diastolic diameter (LVEDd) and left ventricular end-systolic diameter (LVESd) were higher than those in the control group (p<0.05), and the levels of TNF-alpha, IL-6 and myeloperoxidase (MPO) were increased (p<0.05). The number of apoptotic cells in myocardial tissues in the SHR group was larger than that in the other two groups (p<0.05). In the SHR group, the expression levels of Caspase3 and NF-kappaB were remarkably higher than those in the Rosuvastatin group (p<0.05), while the expression levels of Bcl-2 and SIRT1 were remarkably lower than those in the Rosuvastatin group (p<0.05). Rosuvastatin can inhibit myocardial apoptosis in hypertensive rats through up-regulating SIRT1 and down-regulating NF-kappaB. FAU - Ren, Xiangqian AU - Ren X AD - Department of Cardiology, Anning Branch, 940 Hospital of the Joint Service support Force of the Chinese People's Liberation Army, Gansu, 730070, China. yuhuicuo35838@163.com. FAU - Wang, Yi AU - Wang Y AD - Department of Cardiology, Anning Branch, 940 Hospital of the Joint Service support Force of the Chinese People's Liberation Army, Gansu, 730070, China. yuhuicuo35838@163.com. FAU - Han, Lin AU - Han L AD - Department of Cardiology, Anning Branch, 940 Hospital of the Joint Service support Force of the Chinese People's Liberation Army, Gansu, 730070, China. yuhuicuo35838@163.com. FAU - Sun, Zhenzhen AU - Sun Z AD - Department of Cardiology, Anning Branch, 940 Hospital of the Joint Service support Force of the Chinese People's Liberation Army, Gansu, 730070, China. yuhuicuo35838@163.com. FAU - Yuan, Bin AU - Yuan B AD - Department of Cardiology, Anning Branch, 940 Hospital of the Joint Service support Force of the Chinese People's Liberation Army, Gansu, 730070, China. yuhuicuo35838@163.com. LA - eng PT - Journal Article DEP - 20220430 PL - France TA - Cell Mol Biol (Noisy-le-grand) JT - Cellular and molecular biology (Noisy-le-Grand, France) JID - 9216789 RN - 0 (Interleukin-6) RN - 0 (NF-kappa B) RN - 0 (Tumor Necrosis Factor-alpha) RN - 83MVU38M7Q (Rosuvastatin Calcium) RN - EC 3.5.1.- (Sirt1 protein, rat) RN - EC 3.5.1.- (Sirtuin 1) SB - IM MH - Animals MH - *Apoptosis/drug effects MH - Disease Models, Animal MH - Interleukin-6/pharmacology MH - Myocardium/metabolism MH - *NF-kappa B/metabolism MH - Rats MH - Rats, Inbred SHR MH - *Rosuvastatin Calcium/pharmacology/therapeutic use MH - Signal Transduction MH - *Sirtuin 1/genetics/metabolism MH - Tumor Necrosis Factor-alpha/pharmacology EDAT- 2022/08/22 06:00 MHDA- 2022/08/24 06:00 CRDT- 2022/08/21 16:16 PHST- 2022/04/25 00:00 [received] PHST- 2022/08/21 16:16 [entrez] PHST- 2022/08/22 06:00 [pubmed] PHST- 2022/08/24 06:00 [medline] AID - 10.14715/cmb/2022.68.4.23 [doi] PST - epublish SO - Cell Mol Biol (Noisy-le-grand). 2022 Apr 30;68(4):194-201. doi: 10.14715/cmb/2022.68.4.23.